Acquired Factor VIII Inhibitor Associated with a Prostatic Cancer: Simultaneous Occurrence and Healing

Thromb Haemost 1995; 73(02): 327-328
DOI: 10.1055/s-0038-1653775

Letter to the Editor

Schattauer GmbH Stuttgart

François Lionnet

¹Department of Hematology, Hôpital d’Argenteuil, Argenteuil, France

,

Marc Pulik

¹Department of Hematology, Hôpital d’Argenteuil, Argenteuil, France

,

Philippe Genet

¹Department of Hematology, Hôpital d’Argenteuil, Argenteuil, France

,

Gérard Lucas

²Department of Urology,, Hôpital d’Argenteuil, Argenteuil, France

,

Jean-Pierre Sollet

³Department of Intensive Care Unit, Hôpital d’Argenteuil, Argenteuil, France

References
1 Kessler CM. An introduction to factor VIII inhibitors: the detection and quantification. Am J Med 1991; 91 Suppl (Suppl. 05) A 1S-5S
2 Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost 1981; 45: 200-203
3 Sack GH, Levin J, Bell WR. Trousseau’s syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. Medicine 1977; 56: 1-37
4 Hultin MB. Acquired inhibitors in malignant and nonmalignant disease states. Am J Med 1991; 91 (Suppl. 05) A 9S-13S
5 Preminger GM, Knupp CL, Hindsley JP, Jenkins JM, Fried FA, Blatt PM. Spontaneously acquired anti-factor VIII antibodies: report of a patient with adenocarcinoma of the prostate. J Urol 1984; 131: 1182-1181
6 Sultan Y, Kazatchkine MD, Maisonneuve P, Nydegger UE. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet 1984; 2: 765-768
7 Manchul LA, Jin A, Pritchard KI, Tenembaum J, Boyd NF, Lee P, German-son T, Gordon DA. The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis. Arch Intern Med 1985; 145: 1835-1839
8 Garcias VA, Herr HW. Henoch-Schonlein purpura associated with cancer of prostate. Urology 1982; 19: 155-158